EDGAR Filing Documents for 0001193125-15-408298

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-15-408298

Filing Date

2015-12-21

Accepted

2015-12-21 06:08:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS	d55401ds3.htm	S-3	278613
2	EX-4.5	d55401dex45.htm	EX-4.5	299562
3	EX-4.8	d55401dex48.htm	EX-4.8	105894
4	EX-4.9	d55401dex49.htm	EX-4.9	105362
5	EX-4.10	d55401dex410.htm	EX-4.10	94895
6	EX-5.1	d55401dex51.htm	EX-5.1	24443
7	EX-12.1	d55401dex121.htm	EX-12.1	17217
8	EX-23.1	d55401dex231.htm	EX-23.1	1821
9	GRAPHIC	g55401g13h21.jpg	GRAPHIC	2554
10	GRAPHIC	g55401img001.jpg	GRAPHIC	6907
	Complete submission text file	0001193125-15-408298.txt		942136

Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5

Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223

AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)